Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
XBP1ペプチド、CD138ペプチドおよびCS1ペプチド
Document Type and Number:
Japanese Patent JP2011523560
Kind Code:
A
Abstract:
A pharmaceutical composition can be used for treating or preventing cancer; the composition comprising a pharmaceutically acceptable carrier and a peptide, a nucleic acid encoding said peptide, a vector comprising said nucleic acid, or a cell comprising said nucleic acid, peptide or vector; wherein said peptide consists of an amino acid sequence that is at least 66% identical to any one of SEQ ID NOS: 15-18.

More Like This:
JP2007277265COMPOSITION AND METHOD FOR ENHANCING ANTITUMOR IMMUNITY AND GENE THERAPY
JP2011524743Natural killer p30 (NKp30) dysfunction and its biological uses
JP2010213718EXPRESSION CASSETTE AND VECTOR FOR TRANSIENT OR STABLE EXPRESSION OF EXOGENOUS MOLECULE
Inventors:
Mansi, Nikircy.
Fly
Anderson, Kennis Sea.
Application Number:
JP2011512566A
Publication Date:
August 18, 2011
Filing Date:
June 01, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Dana-Farber Cancer Institute, Inc.
International Classes:
C12N15/09; A61K35/14; A61K39/00; A61K39/39; A61P35/00; A61P37/04; C07K11/00; C07K19/00; C12N5/10; C12P21/02
Domestic Patent References:
JP2007503465A2007-02-22
JP2007530675A2007-11-01
Foreign References:
WO2008019378A12008-02-14
WO2008019376A22008-02-14
US20030113332A12003-06-19
Other References:
JPN6010014502; Ｊ．　Ｉｍｍｕｎｏｌ． Ｖｏｌ．１６７，　Ｎｏ．１０, 20011115, ｐｐ．５５１７-５５２１
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita



 
Previous Patent: 生合成に関与する新規の遺伝子

Next Patent: ＦＧＦ２１突然変異体及びその使用